Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

TRAUMEEL for Pain After Fracture of Neck of Femur

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00307905
Recruitment Status : Withdrawn (Anticipation of inadequate recruitment according to current format.)
First Posted : March 28, 2006
Last Update Posted : October 29, 2010
Information provided by:
Shaare Zedek Medical Center

Brief Summary:

We hypothesize that Traumeel S is more effective than placebo in reducing 48-hour mean cumulative morphine consumption in patients scheduled for surgical correction of fracture of neck of hip.

224 patients, meeting all inclusion and none of exclusion criteria, will be enrolled in the trial. Patients will be randomized to receive either intraoperative injection and post operative oral Traumeel S Tablets or placebo injection (normal saline) and indistinguishable oral placebo tablets. Baseline measurements of relevant outcome measures will taken preoperatively. Immediately after surgery, patients will receive an initial dose of morphine of 0.1mg/kg body weight. Patients will take the oral study medication for 21 days. Every four hours after surgery, patients will be asked to grade their pain on an NRS. Subsequent doses of morphine will be calculated based upon the patient's weight and current NRS, according to a preplanned scheme. Patients will be permitted to request additional morphine, beyond their calculated dose.

Condition or disease Intervention/treatment Phase
Pain Fracture of Neck of Femur Drug: Traumeel S Drug: Placebo remedy Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 224 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Randomised, Double - Blind, Placebo Controlled Clinical Trial to Assess the Efficacy of the Homeopathic Medication TRAUMEEL S in Controlling Post-operative Pain After Fracture of Neck of Femur
Study Start Date : January 2011
Estimated Primary Completion Date : June 2012

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: A
Drug: Traumeel S
homeopathic remedy

Placebo Comparator: B
placebo remedy
Drug: Placebo remedy
identical size, shape and taste of treatment medication

Primary Outcome Measures :
  1. Cumulative 48-hour postoperative morphine consumption [ Time Frame: 48h ]

Secondary Outcome Measures :
  1. Secondary: AUC of NRS scores for first 48 hrs.; [ Time Frame: 48h ]
  2. AUC of NRS scores for days 14-17.; [ Time Frame: 17d ]
  3. Composite measure of pain intensity and opiate consumption; [ Time Frame: 17d ]
  4. Number of primary oral analgesic tablets ingested between days 14-17; [ Time Frame: 17d ]
  5. ESR and hs-CPR at three and six days and six weeks; [ Time Frame: 42d ]
  6. IL-6 at three and six days; [ Time Frame: 6d ]
  7. Post operative blood loss; [ Time Frame: 48h ]
  8. WOMAC; [ Time Frame: 17d ]
  9. Safety of post operative treatment [ Time Frame: 17d ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients of either sex undergoing surgical correction of unilateral fracture of neck of hip.
  • Age over 18 years.
  • Signature upon informed consent form

Exclusion Criteria:

  • Participation in another clinical trial within 4 weeks prior to enrollment.
  • Refused to give verbal consent to the telephone interviews
  • Impossibility to be reached during the 14-17 days post operative
  • Inability to comply with the study protocol for any other reason
  • Previous major surgical procedure on ipsilateral hip.
  • Current use of analgesics for any other reason.
  • A history of chronic pain syndrome.
  • Abused legal or illicit drug use.
  • Hypersensitivity to botanicals of the Compositae family
  • Known sensitivity to paracetamol, codeine or tramadol.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00307905

Layout table for location information
Dept. of Orthopedic Surgery, Shaare Zedek Medical Center
Jerusalem, Israel
Sponsors and Collaborators
Shaare Zedek Medical Center
Layout table for investigator information
Principal Investigator: Menachem Oberbaum, MD Shaare Zedek Medical Center, Jerusalem, Israel

Layout table for additonal information
Responsible Party: Menachem Oberbaum, MD, Shaare Zedek Medical Center, Identifier: NCT00307905    
Other Study ID Numbers: NoF 06 CTIL
First Posted: March 28, 2006    Key Record Dates
Last Update Posted: October 29, 2010
Last Verified: October 2010
Keywords provided by Shaare Zedek Medical Center:
traumeel s
Fracture of neck of femur
Surgical correction of fracture of neck of hip
Additional relevant MeSH terms:
Layout table for MeSH terms
Fractures, Bone
Femoral Neck Fractures
Wounds and Injuries
Hip Fractures
Femoral Fractures
Hip Injuries
Leg Injuries